Published in J Immunol on June 01, 2005
Fulminant encephalopathy with basal ganglia hyperintensities in HIV-infected drug users. Neurology (2011) 1.44
HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. J Neurochem (2006) 1.31
Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol (2011) 1.29
Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells. J Neuroimmune Pharmacol (2008) 1.16
Editorial neuroAIDS review. AIDS (2011) 1.10
Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res (2006) 0.99
DC-specific ICAM-3-grabbing nonintegrin mediates internalization of HIV-1 into human podocytes. Am J Physiol Renal Physiol (2010) 0.94
Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim Biophys Acta (2007) 0.93
Cocaine and HIV-1 interplay: molecular mechanisms of action and addiction. J Neuroimmune Pharmacol (2011) 0.93
Cocaine exposure enhances permissiveness of quiescent T cells to HIV infection. J Leukoc Biol (2013) 0.93
Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse. J Clin Immunol (2009) 0.88
Cocaine enhances HIV-1 infectivity in monocyte derived dendritic cells by suppressing microRNA-155. PLoS One (2013) 0.87
Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission. Life Sci (2010) 0.87
Glial modulators as potential treatments of psychostimulant abuse. Adv Pharmacol (2014) 0.86
Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells. Life Sci (2010) 0.86
HIV infection and drugs of abuse: role of acute phase proteins. J Neuroinflammation (2013) 0.85
RNAi-directed inhibition of DC-SIGN by dendritic cells: prospects for HIV-1 therapy. AAPS J (2005) 0.84
Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification. Free Radic Biol Med (2014) 0.83
Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells. Immunol Invest (2009) 0.83
Differential regulation of the attachment of Kaposi's sarcoma-associated herpesvirus (KSHV)-infected human B cells to extracellular matrix by KSHV-encoded gB and cellular alphaV integrins. Cell Microbiol (2008) 0.81
Upregulation of serotonin transporter by alcohol in human dendritic cells: possible implication in neuroimmune deregulation. Alcohol Clin Exp Res (2009) 0.78
Cocaine-mediated impact on HIV infection in humanized BLT mice. Sci Rep (2015) 0.78
The effects of cocaine on HIV transcription. J Neurovirol (2015) 0.78
Immunopathogenesis of HIV infection in cocaine users: role of arachidonic acid. PLoS One (2014) 0.77
Interaction of drugs of abuse and microRNA with HIV: a brief review. Front Microbiol (2015) 0.76
Impact of cocaine abuse on HIV pathogenesis. Front Microbiol (2015) 0.76
Cocaine Enhances HIV-1 Transcription in Macrophages by Inducing p38 MAPK Phosphorylation. Front Microbiol (2016) 0.75
DJ1 expression downregulates in neuroblastoma cells (SK-N-MC) chronically exposed to HIV-1 and cocaine. Front Microbiol (2015) 0.75
Cocaine Enhances DC to T-cell HIV-1 Transmission by Activating DC-SIGN/LARG/LSP1 Complex and Facilitating Infectious Synapse Formation. Sci Rep (2017) 0.75
Cocaine Use May be Associated with Increased Depression in Persons Infected with HIV. AIDS Behav (2016) 0.75
Successful treatment of 3 patients with recurrent idiopathic angioedema with omalizumab. J Allergy Clin Immunol (2007) 1.69
Molecular classification of thyroid nodules using high-dimensionality genomic data. J Clin Endocrinol Metab (2010) 1.57
Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells. Cancer Res (2004) 1.44
The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin Vaccine Immunol (2006) 1.41
Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res (2008) 1.32
Nanotechnology approach for drug addiction therapy: gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons. Proc Natl Acad Sci U S A (2009) 1.27
Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagn Lab Immunol (2004) 1.14
MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier. Brain Res (2009) 1.12
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient. J Clin Microbiol (2004) 1.11
Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier. Bioconjug Chem (2008) 1.11
Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis. Mol Diagn Ther (2006) 1.11
Morphine modulates chemokine gene regulation in normal human astrocytes. Clin Immunol (2005) 1.09
Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol (2002) 1.08
Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology (2006) 1.07
The flavonoid, quercetin, differentially regulates Th-1 (IFNgamma) and Th-2 (IL4) cytokine gene expression by normal peripheral blood mononuclear cells. Biochim Biophys Acta (2002) 1.06
Tight junction regulation by morphine and HIV-1 tat modulates blood-brain barrier permeability. J Clin Immunol (2008) 1.06
Genomic Analysis Highlights the Role of the JAK-STAT Signaling in the Anti-proliferative Effects of Dietary Flavonoid-'Ashwagandha' in Prostate Cancer Cells. Evid Based Complement Alternat Med (2008) 1.04
Morphine exacerbates HIV-1 viral protein gp120 induced modulation of chemokine gene expression in U373 astrocytoma cells. Curr HIV Res (2005) 1.00
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles. Curr HIV Res (2010) 0.99
Proteomic analysis of the effects of cocaine on the enhancement of HIV-1 replication in normal human astrocytes (NHA). Brain Res (2006) 0.99
Proteomic analyses of methamphetamine (METH)-induced differential protein expression by immature dendritic cells (IDC). Biochim Biophys Acta (2007) 0.93
The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate (2008) 0.93
Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. J Neuroimmunol (2004) 0.92
Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapy. Theranostics (2012) 0.91
Gene Silencing of Human Neuronal Cells for Drug Addiction Therapy using Anisotropic Nanocrystals. Theranostics (2012) 0.90
Modulation of the proteome of peripheral blood mononuclear cells from HIV-1-infected patients by drugs of abuse. J Clin Immunol (2009) 0.88
Anti-HIV-1 nanotherapeutics: promises and challenges for the future. Int J Nanomedicine (2012) 0.88
Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma. Clin Immunol (2008) 0.88
Overexpression of MMP-9 contributes to invasiveness of prostate cancer cell line LNCaP. Immunol Invest (2011) 0.88
Nanoparticle based galectin-1 gene silencing, implications in methamphetamine regulation of HIV-1 infection in monocyte derived macrophages. J Neuroimmune Pharmacol (2012) 0.87
Methamphetamine modulates DC-SIGN expression by mature dendritic cells. J Neuroimmune Pharmacol (2006) 0.85
Well-defined degradable cationic polylactide as nanocarrier for the delivery of siRNA to silence angiogenesis in prostate cancer. Adv Healthc Mater (2012) 0.84
Methamphetamine and HIV-1 gp120 effects on lipopolysaccharide stimulated matrix metalloproteinase-9 production by human monocyte-derived macrophages. Immunol Invest (2011) 0.84
RNAi-directed inhibition of DC-SIGN by dendritic cells: prospects for HIV-1 therapy. AAPS J (2005) 0.84
Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease. Biochem Biophys Res Commun (2010) 0.83
Proteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cells. Immunol Invest (2009) 0.83
Suppression of MMP-9 expression in brain microvascular endothelial cells (BMVEC) using a gold nanorod (GNR)-siRNA nanoplex. Immunol Invest (2011) 0.83
Grape seed extract proanthocyanidins downregulate HIV-1 entry coreceptors, CCR2b, CCR3 and CCR5 gene expression by normal peripheral blood mononuclear cells. Biol Res (2002) 0.83
Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth. Neoplasia (2005) 0.81
Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008-2011. Viral Immunol (2014) 0.81
Single nucleotide polymorphisms (SNPs) in key cytokines may modulate food allergy phenotypes. Eur Food Res Technol (2012) 0.81
SARS coronavirus spike protein-induced innate immune response occurs via activation of the NF-kappaB pathway in human monocyte macrophages in vitro. Virus Res (2009) 0.81
Heroin-Induces Differential Protein Expression by Normal Human Astrocytes (NHA). Am J Infect Dis (2006) 0.81
Chronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factor. Pain (2015) 0.81
Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages. J Immunol (2012) 0.80
Therapeutic targeting of "DARPP-32": a key signaling molecule in the dopiminergic pathway for the treatment of opiate addiction. Int Rev Neurobiol (2009) 0.79
Synthesis of luminescent near-infrared AgInS2 nanocrystals as optical probes for in vivo applications. Theranostics (2013) 0.79
Nanotherapeutics Using an HIV-1 Poly A and Transactivator of the HIV-1 LTR-(TAR-) Specific siRNA. Patholog Res Int (2011) 0.78
Grape seed extract activates Th1 cells in vitro. Clin Diagn Lab Immunol (2002) 0.78
Photopheresis in HIV-1 infected patients utilizing benzoporphyrin derivative (BPD) verteporfin and light. Curr HIV Res (2008) 0.78
Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells. Nanoscale (2014) 0.78
Prostate-Specific Antigen Modulates the Expression of Genes Involved in Prostate Tumor Growth. Neoplasia (2005) 0.78
Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities. Prostate (2011) 0.78
Two step procedure for purification of enzymatically active prostate-specific antigen from seminal plasma. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.77
The Durability of Endoscopic Therapy for Treatment of Barrett's Metaplasia, Dysplasia, and Mucosal Cancer After Nissen Fundoplication. J Gastrointest Surg (2015) 0.77
Nanoparticle-mediated targeted delivery of antiretrovirals to the brain. Methods Enzymol (2012) 0.77
New Insights into the Disease Progression Control Mechanisms by Comparing Long-Term-Nonprogressors versus Normal-Progressors among HIV-1-Positive Patients Using an Ion Current-Based MS1 Proteomic Profiling. J Proteome Res (2015) 0.76
Machine learning from concept to clinic: reliable detection of BRAF V600e DNA mutations in thyroid nodules using high-dimensional RNA expression data. Pac Symp Biocomput (2015) 0.76
In vitro and animal models of human immunodeficiency virus infection of the central nervous system. Clin Diagn Lab Immunol (2002) 0.76
Preclinical and clinical performance of the Efoora test, a rapid test for detection of human immunodeficiency virus-specific antibodies. J Clin Microbiol (2005) 0.75
Proteomic Approach to Evaluate Mechanisms That Contribute to Food Allergenicity: Comparative 2D-DIGE Analysis of Radioallergosorbent Test Positive and Negative Patients. Int J Proteomics (2011) 0.75
Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction. J Neuroimmune Pharmacol (2015) 0.75
Quantum rods as nanocarriers of gene therapy. Drug Deliv (2012) 0.75
Data linkage and subject anonymity for HIV testing. AIDS Public Policy J (1990) 0.75
Serum interferon inhibitor declines in patients with HIV-1 infection after a change in antiretroviral therapy. Immunol Invest (2003) 0.75